Related Experiment Video

Updated: Dec 9, 2025

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

9.1K

Blue Toe in an Oncological Patient: Challenge

Juan F Mir-Bonafé1, Marc Mir-Bonafé2, José M Mir-Bonafé3

  • 1Department of Dermatology, Hospital Son Llàtzer, Palma de Mallorca, Spain.

The American Journal of Dermatopathology
|September 15, 2020
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

14.1K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

660

Related Experiment Videos

Last Updated: Dec 9, 2025

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

9.1K
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

14.1K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

660

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

9.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.6K

Articles linked to this work by shared authors, journal, and citation graph.

Delayed lichenoid immune-related adverse event after nivolumab discontinuation.

Skin health and disease·2026

High-Potency Depigmenting Mask Delivered via 1,927-nm Fractional Laser in Refractory Melasma: A Pilot Case Series.

Case reports in dermatology·2026

The impact of the six pillars of lifestyle medicine on the biology of skin aging.

Frontiers in aging·2026

Biological Photoprotection: A Review of its Mechanisms, Evidence, and Clinical Implications.

Dermatology and therapy·2026

Exposome Risk Factors for Vitiligo: A Systematic Evidence Review.

American journal of clinical dermatology·2026

Topical and Oral Photoprotection for the Treatment of Photodermatoses. A Survey of 90 Dermatologists.

Photobiomodulation, photomedicine, and laser surgery·2026

Low-Grade and Intermediate-Grade Apocrine Intraductal Carcinoma Arising in a Nevus Sebaceous of Jadassohn.

The American Journal of dermatopathology·2026

A Nomogram for the Diagnosis of Plaque Psoriasis Using Histopathological Characteristics.

The American Journal of dermatopathology·2026

ALK1-Negative Epithelioid Histiocytoma: Lessons From a Rare Case.

The American Journal of dermatopathology·2026

Cutaneous Neurotrophic Tyrosine Receptor Kinase-Rearranged Spindle Cell Neoplasm: A Diagnostic Dilemma.

The American Journal of dermatopathology·2026

Pilomatricomal Horn With Confirmed CTNNB1 Mutation: A Rarely Reported Follicular Tumor.

The American Journal of dermatopathology·2026

Morphologic and Molecular Differences of BAP1 Melanocytomas and BAP1 Inactivated Melanomas.

The American Journal of dermatopathology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us